Table I.
Patient characteristics and treatment methods.
| Brachytherapy | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Patient no. | Gender | Age (years) | Main primary site | No. of lesions | Tumor size (small, <30 mm; large, >50 mm) | Other metastatic sites | Limited surgery | Dose, Gy | Fractions, no. | Electron boost | IL-2 | Chemotherapy |
| 1 | F | 69.8 | Occipital | Multiple | Small | None | None | 60 | 20 | Local+arterial | None | |
| 2 | F | 67.7 | Parietal | Single | Middle | None | Done | 48 | 16 | 12 Gr/6 fractions | None | None |
| 3 | F | 83.4 | Parietal | Single | Small | None | None | 60 | 20 | None | None | |
| 4 | M | 91.9 | Temporal | Multiple | Small | None | None | 45 | 15 | Local | None | |
| 5 | M | 81.3 | Parietal | Multiple | Small | Cervical lymph nodes | None | 60 | 20 | Local | None | |
| 6 | M | 91.7 | Parietal | Single | Middle | None | None | 60 | 20 | Local | None | |
| 7 | M | 84.2 | Parietal | Single | Middle | None | None | 45 | 15 | Local | None | |
| 8 | M | 88.4 | Parietal | Single | Large | None | None | 45 | 15 | Local | Paclitaxel | |
| 9 | M | 80.9 | Parietal | Single | Small | None | Done | 45 | 15 | Local | None | |
IL, interleukin; F, female; m, male.